LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

Search

McKesson Corp

Geschlossen

BrancheGesundheitswesen

981.54 1.07

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

972.54

Max

986.33

Schlüsselkennzahlen

By Trading Economics

Einkommen

40M

1.3B

Verkäufe

3B

106B

KGV

Branchendurchschnitt

27.395

108.767

Dividendenrendite

0.32

Gewinnspanne

1.177

Angestellte

43,000

EBITDA

374M

1.8B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+1.61% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.32%

2.21%

Nächstes Ergebnis

7. Mai 2026

Nächste Dividendenausschüttung

1. Apr. 2026

Nächstes Ex-Dividendendatum

2. März 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

12B

117B

Vorheriger Eröffnungskurs

980.47

Vorheriger Schlusskurs

981.54

Nachrichtenstimmung

By Acuity

26%

74%

61 / 352 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

McKesson Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

27. Feb. 2026, 23:53 UTC

Heiße Aktien

Stocks to Watch: Aardvark Therapeutics, Blue Moon Metals

27. Feb. 2026, 22:23 UTC

Akquisitionen, Fusionen, Übernahmen

Blue Moon Metals To Acquire Apex Germanium Mine From Teck Subsidiary

27. Feb. 2026, 17:55 UTC

Heiße Aktien

Toronto Stocks Decline, But Remain On Track for Weekly Gains

27. Feb. 2026, 23:46 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix Walks Away a Winner After Losing Warner Bros. to Paramount -- Barrons.com

27. Feb. 2026, 23:33 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Issuing $47 Billion of Equity at Nearly 20% Premium to Current Stock Price -- Barrons.com

27. Feb. 2026, 21:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Tech, Media & Telecom Roundup: Market Talk

27. Feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

27. Feb. 2026, 21:30 UTC

Ergebnisse

Solventum Beat Wall Street Earnings Estimates. The Stock Falls. -- Barrons.com

27. Feb. 2026, 21:30 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Warner Terminates Netflix Deal, Ending Monthslong Saga -- Market Talk

27. Feb. 2026, 21:20 UTC

Akquisitionen, Fusionen, Übernahmen

Blue Moon Metals to Buy Apex Germanium and Gallium Mine From Teck >BMM

27. Feb. 2026, 21:17 UTC

Ergebnisse

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

27. Feb. 2026, 21:10 UTC

Akquisitionen, Fusionen, Übernahmen

Blue Moon Metals Evaluating Options for a New Processing Line at Springer Complex to Process the Apex Material

27. Feb. 2026, 21:09 UTC

Akquisitionen, Fusionen, Übernahmen

Blue Moon Metals to Acquire the Apex Germanium and Gallium Mine From Teck

27. Feb. 2026, 21:00 UTC

Ergebnisse

Nike: 3Q Results to Be Released March 31 to Accommodate for Several Holidays >NKE

27. Feb. 2026, 20:31 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix Receives $2.8B Termination Fee Under Terminated Warner Bros. Discovery Deal

27. Feb. 2026, 20:24 UTC

Market Talk

Oil Gains on Increased Risk of U.S.-Iran Conflict -- Market Talk

27. Feb. 2026, 20:23 UTC

Market Talk

U.S. Natural Gas Futures Post Modest Gains -- Market Talk

27. Feb. 2026, 20:12 UTC

Market Talk

Nike Seen With Further Challenges in China -- Market Talk

27. Feb. 2026, 19:44 UTC

Market Talk

Gold Caps Historic Month -- Market Talk

27. Feb. 2026, 19:39 UTC

Ergebnisse

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

27. Feb. 2026, 19:38 UTC

Ergebnisse

Earnings Could Push the Stock Market Higher. Too Bad About Everything Else. -- Barrons.com

27. Feb. 2026, 18:53 UTC

Akquisitionen, Fusionen, Übernahmen

Largest U.S. Pension Takes Stake in a Hot Semi Stock, Buys More Nvidia and IonQ -- Barrons.com

27. Feb. 2026, 18:45 UTC

Ergebnisse

Quantum Computing Is No Longer a Speculative Bet. IonQ's Surging Stock Drives Home That Point. -- Barrons.com

27. Feb. 2026, 18:45 UTC

Market Talk

Bitcoin Stays Vulnerable in Choppy Geopolitical Situation -- Market Talk

27. Feb. 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

27. Feb. 2026, 17:07 UTC

Ergebnisse

Pemex Cuts 4Q Loss As Operating Results Improve

27. Feb. 2026, 17:00 UTC

Market Talk

Corn Rides Oil Momentum Higher -- Market Talk

27. Feb. 2026, 16:31 UTC

Market Talk

Canadian Economy Shows Resilience -- Market Talk

27. Feb. 2026, 16:17 UTC

Market Talk

Canada Economy is Struggling But More Rate Cuts Still a Long Shot -- Market Talk

27. Feb. 2026, 15:49 UTC

Ergebnisse

Quantum Computing No Longer a Speculative Bet. IonQ's Surging Stock Drives Home That Point. -- Barrons.com

Peer-Vergleich

Kursveränderung

McKesson Corp Prognose

Kursziel

By TipRanks

1.61% Vorteil

12-Monats-Prognose

Durchschnitt 990.1 USD  1.61%

Hoch 1,107 USD

Tief 885 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für McKesson Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

11 ratings

9

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

681.92 / 707.28Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

No Evidence

Langfristig

No Evidence

Stimmung

By Acuity

61 / 352 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat